These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18088270)

  • 1. Where is the evidence that p-glycoprotein limits brain uptake of antiepileptic drug and contributes to drug resistance in epilepsy?
    Anderson GD; Shen DD
    Epilepsia; 2007 Dec; 48(12):2372-4. PubMed ID: 18088270
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug transporters in the epileptic brain.
    Löscher W
    Epilepsia; 2007; 48 Suppl 1():8-13. PubMed ID: 17316407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDR1/ABCB1 polymorphisms and multidrug resistance in epilepsy: in and out of fashion.
    Löscher W; Delanty N
    Pharmacogenomics; 2009 May; 10(5):711-3. PubMed ID: 19450121
    [No Abstract]   [Full Text] [Related]  

  • 4. Transporter hypothesis of drug-resistant epilepsy: challenges for pharmacogenetic approaches.
    Potschka H
    Pharmacogenomics; 2010 Oct; 11(10):1427-38. PubMed ID: 21047204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enaminones: Exploring additional therapeutic activities.
    Edafiogho IO; Kombian SB; Ananthalakshmi KV; Salama NN; Eddington ND; Wilson TL; Alexander MS; Jackson PL; Hanson CD; Scott KR
    J Pharm Sci; 2007 Oct; 96(10):2509-31. PubMed ID: 17621683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacogenetic criteria of drug-resistant epilepsy].
    Oros MM
    Lik Sprava; 2012 Dec; (8):71-4. PubMed ID: 23786015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
    Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D
    Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study on brain-to-plasma partition of 10,11-dyhydro-10-hydroxy-5H-dibenzo(b,f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine.
    Marchi N; Guiso G; Rizzi M; Pirker S; Novak K; Czech T; Baumgartner C; Janigro D; Caccia S; Vezzani A
    Epilepsia; 2005 Oct; 46(10):1613-9. PubMed ID: 16190932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance in epilepsy: why is a simple explanation not enough?
    Löscher W; Sills GJ
    Epilepsia; 2007 Dec; 48(12):2370-2. PubMed ID: 18088269
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanisms of drug resistance in epilepsy].
    Lasoń W
    Przegl Lek; 2006; 63(11):1218-20. PubMed ID: 17348420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy.
    Soranzo N; Kelly L; Martinian L; Burley MW; Thom M; Sali A; Kroetz DL; Goldstein DB; Sisodiya SM
    Epilepsia; 2007 Apr; 48(4):674-83. PubMed ID: 17437410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of drug resistance.
    Löscher W
    Epileptic Disord; 2005 Sep; 7 Suppl 1():S3-9. PubMed ID: 16120487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
    Basic S; Hajnsek S; Poljakovic Z; Basic M
    Epilepsia; 2006 Feb; 47(2):449; author reply 450. PubMed ID: 16499776
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug resistance in epilepsy: more twists in the tale.
    Sisodiya SM; Goldstein DB
    Epilepsia; 2007 Dec; 48(12):2369-70. PubMed ID: 18088268
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy.
    Kwan P; Brodie MJ
    Epilepsia; 2005 Feb; 46(2):224-35. PubMed ID: 15679503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of antiepileptic drug resistance.
    Sisodiya SM
    Curr Opin Neurol; 2003 Apr; 16(2):197-201. PubMed ID: 12644749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein).
    Hodges LM; Markova SM; Chinn LW; Gow JM; Kroetz DL; Klein TE; Altman RB
    Pharmacogenet Genomics; 2011 Mar; 21(3):152-61. PubMed ID: 20216335
    [No Abstract]   [Full Text] [Related]  

  • 18. Signaling to P-glycoprotein-A new therapeutic target to treat drug-resistant epilepsy?
    Hartz AM; Notenboom S; Bauer B
    Drug News Perspect; 2009 Sep; 22(7):393-7. PubMed ID: 19890496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of ABCB1 genetic variants 3435C>T and 2677G>T to ABCB1 mRNA and protein expression in brain tissue from refractory epilepsy patients.
    Mosyagin I; Runge U; Schroeder HW; Dazert E; Vogelgesang S; Siegmund W; Warzok RW; Cascorbi I
    Epilepsia; 2008 Sep; 49(9):1555-61. PubMed ID: 18494787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoproteomics-based reconstruction of in vivo P-glycoprotein function at blood-brain barrier and brain distribution of substrate verapamil in pentylenetetrazole-kindled epilepsy, spontaneous epilepsy, and phenytoin treatment models.
    Uchida Y; Ohtsuki S; Terasaki T
    Drug Metab Dispos; 2014 Oct; 42(10):1719-26. PubMed ID: 25061162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.